Kidney RISE: Randomized Integrated Supportive CarE Trial

The purpose of study is to investigate whether adding palliative care to usual chronic kidney disease (CKD) care improves symptoms and quality of life for people with CKD. The primary objectives are to 1) determine efficacy of Kidney Palliative Care (KPC) integrated with CKD care on symptom burden compared with usual CKD care, 2) identify clinical and demographic factors associated with differential responses to KPC, and 3) characterize participant and provider experiences with kidney care and factors influencing implementation.

NCT Number	NCT07741357
Lead Sponsor	NYU Langone Health Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions	Chronic Kidney Disease (Stages 4 and 5)
Enrollment	280 participants
Start Date	2027-05
Primary Completion	2030-08 (estimated)
Study Completion	2031-01 (estimated)
Updated on ClinicalTrials.gov	2026-08-03